Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study.
COVID-19
Lesotho
SARS-CoV-2
bioaerosol capture device
Journal
IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
27
10
2022
accepted:
28
10
2022
pubmed:
9
11
2022
medline:
9
11
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.
Identifiants
pubmed: 36345367
doi: 10.1016/j.ijregi.2022.10.007
pii: S2772-7076(22)00133-3
pmc: PMC9630292
doi:
Types de publication
Journal Article
Langues
eng
Pagination
163-164Informations de copyright
© 2022 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. AL2 Impact and 3M Company provided the bioaerosol capture devices and gave technical advice, but were not involved in data analysis.
Références
Clin Infect Dis. 2021 May 18;72(10):e652-e654
pubmed: 32857833
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Environ Res. 2020 Sep;188:109819
pubmed: 32569870
Diagnostics (Basel). 2022 Sep 17;12(9):
pubmed: 36140647
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Health Sci Rep. 2021 May 07;4(2):e275
pubmed: 33977157
Sci Rep. 2021 Apr 28;11(1):9221
pubmed: 33911131
Front Med (Lausanne). 2021 May 07;8:615099
pubmed: 34026773
mBio. 2021 Oct 26;12(5):e0252721
pubmed: 34663099